ARCHIVES

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

This article is from The Cancer Letter archive.

Vol. 35 No. 41 | November 6, 2009

Download PDF Visit The Full Archive

Related Articles

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975

The March: Research Task Force Calls For $10 Billion For NCI In 5 Years

October 23, 1998

Children, Parents Differ In Decisionmaking On Cancer Treatment, Survivor Study Finds

July 29, 2005

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

AHCPR Invites Ideas for Outcomes Research

June 7, 1996